TETRALOGIC PHARMACEUTICALS CORP Forms 3, 4 and 5: Other

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 1 rows, 1 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

2013-12-17: Reporting owner Reed Douglas MD; Form 4; Security Series C Convertible Stock; Transaction C Conversion of derivative security.

All rows

Transaction date	Reporting owner	Form	Security	Transaction	Shares	Price	Price that day	Filing
2013-12-17	Reed Douglas MD Director	4	Series C Convertible Stock Derivative · Indirect · See footnotes	C Conversion of derivative security	−780,980 0 owned after	no price filed		2013-12-19